Literature DB >> 22806326

Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years.

X Huang1, W B Liu, L N Men, H Y Feng, Y Li, C M Luo, L Qiu.   

Abstract

The objectives of the study are to study the clinical features of myasthenia gravis in southern China. A retrospective study was carried out on all patients who were diagnosed with myasthenia gravis at the First Affiliated Hospital of Sun Yat-sen University during 1987-2009. Of the 2,154 myasthenia gravis patients, the gender ratio (male:female) was 1:1.15. The median age at onset was 18 years. There was a single peak distribution of age at onset, and 44.8 % were children (≤ 14 years) at first onset. 1,766 patients (82.0 %) only had ocular symptoms at onset. 1,451 patients (67.4 %) were classified as Osserman grade I. 250 unselected patients received anti-acetylcholine receptor antibodies test, in which only 51.2 % were positive. Computed tomography scan/magnetic resonance Imaging of chest were done in 1,354 patients, of which 899 patients (66.4 %) had thymic hyperplasia and 201(14.8 %) had thymoma. There were 150 patients (7.0 %) with myasthenia gravis combined with other autoimmune diseases, in which hyperthyroidism was most common (84 %). 189 (8.8 %) patients experienced 267 episodes of crisis. The rate of family myasthenia gravis was 1.6 % (35/2,154). In conclusion, the clinical features and demography of myasthenia gravis patients in this study are significantly different from prior studies on other regions and ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22806326     DOI: 10.1007/s10072-012-1157-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  16 in total

1.  A study of myasthenia gravis in patients with and without thymoma.

Authors:  A Roy; J Kalita; U K Misra; D Kar; A Agarwal; S K Misra
Journal:  Neurol India       Date:  2000-12       Impact factor: 2.117

2.  Epidemiology of seropositive myasthenia gravis in Greece.

Authors:  K Poulas; E Tsibri; A Kokla; D Papanastasiou; T Tsouloufis; M Marinou; P Tsantili; T Papapetropoulos; S J Tzartos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

3.  Mortality and survival in myasthenia gravis: a Danish population based study.

Authors:  P B Christensen; T S Jensen; I Tsiropoulos; T Sørensen; M Kjaer; E Højer-Pedersen; M J Rasmussen; E Lehfeldt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

4.  Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.

Authors:  Natalie Tsinzerling; Ann-Kari Lefvert; Georg Matell; Ritva Pirskanen-Matell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-12       Impact factor: 10.154

5.  Ocular myasthenia gravis coincident with thyroid ophthalmopathy.

Authors:  A Yaman; H Yaman
Journal:  Neurol India       Date:  2003-03       Impact factor: 2.117

6.  Myasthenic Crisis.

Authors:  Jawad F. Kirmani; Abutaher M. Yahia; Adnan I. Qureshi
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

7.  Treatment and outcome of myasthenia gravis: retrospective multi-center analysis of 470 Japanese patients, 1999-2000.

Authors:  Naoki Kawaguchi; Satoshi Kuwabara; Yuko Nemoto; Toshio Fukutake; Yoichi Satomura; Kimiyoshi Arimura; Mitsuhiro Osame; Takamichi Hattori
Journal:  J Neurol Sci       Date:  2004-09-15       Impact factor: 3.181

8.  Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy.

Authors:  D Guidetti; R Sabadini; M Bondavalli; S Cavalletti; M Lodesani; R Mantegazza; V Cosi; F Solime
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

9.  Myasthenia gravis: a study from India.

Authors:  B S Singhal; Nisha S Bhatia; T Umesh; Suresh Menon
Journal:  Neurol India       Date:  2008 Jul-Sep       Impact factor: 2.117

10.  Thymomas: a cytological and immunohistochemical study, with emphasis on lymphoid and neuroendocrine markers.

Authors:  Borislav A Alexiev; Cinthia B Drachenberg; Allen P Burke
Journal:  Diagn Pathol       Date:  2007-05-11       Impact factor: 2.644

View more
  14 in total

Review 1.  Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis.

Authors:  Kai Zhu; Jiaoxing Li; Xin Huang; Wei Xu; Weibin Liu; Jiaxin Chen; Pei Chen; Huiyu Feng
Journal:  Neurol Sci       Date:  2017-07-13       Impact factor: 3.307

2.  Long-term outcome of 424 childhood-onset myasthenia gravis patients.

Authors:  Mengcui Gui; Xuan Luo; Jing Lin; Yue Li; Min Zhang; Xiaofan Zhang; Mingshan Yang; Wei Wang; Bitao Bu
Journal:  J Neurol       Date:  2015-01-15       Impact factor: 4.849

3.  The HLA-B*4601-DRB1*0901 haplotype is positively correlated with juvenile ocular myasthenia gravis in a southern Chinese Han population.

Authors:  Hui-Yu Feng; Li-Xuan Yang; Wei-Bin Liu; Xin Huang; Li Qiu; Yan Li
Journal:  Neurol Sci       Date:  2015-05-08       Impact factor: 3.307

4.  User Involvement in Myasthenia Gravis Research.

Authors:  Nils Erik Gilhus; Sandra Iren Barkås Hovland
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

5.  Cholinergic Crisis Caused by Cholinesterase Inhibitors: a Retrospective Nationwide Database Study.

Authors:  Hiroyuki Ohbe; Taisuke Jo; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  J Med Toxicol       Date:  2018-06-15

6.  The effect of steroid treatment and thymectomy on bone age and height development in juvenile myasthenia gravis.

Authors:  Haiyan Wang; Zhe Su; Chuanming Luo; Yan Li; Huiyu Feng; Wei Fang; Chunyan Du; Juan Deng; Fei Yu; Weibin Liu
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

7.  Predictive factors of prolonged mechanical ventilation, overall survival, and quality of life in patients with post-thymectomy myasthenic crisis.

Authors:  Kun-Kun Li; Kai Qian; Yong-Geng Feng; Wei Guo; Qun-You Tan; Bo Deng
Journal:  World J Surg Oncol       Date:  2017-08-08       Impact factor: 2.754

8.  Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China.

Authors:  Xin Huang; Yingkai Li; Huiyu Feng; Pei Chen; Weibin Liu
Journal:  Front Neurol       Date:  2018-02-27       Impact factor: 4.003

9.  The Importance of Sex Stratification in Autoimmune Disease Biomarker Research: A Systematic Review.

Authors:  Kristy Purnamawati; Jamie Ann-Hui Ong; Siddharth Deshpande; Warren Kok-Yong Tan; Nihar Masurkar; Jackson Kwee Low; Chester Lee Drum
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

10.  Local use of dexamethasone in the treatment of ocular myasthenia gravis.

Authors:  Minghua Shi; Yingjia Ye; Junping Zhou; Aijiao Qin; Jing Cheng; Hongxing Ren
Journal:  BMC Ophthalmol       Date:  2020-10-28       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.